-
Start Preamble
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 31, 2022. Such persons may also file a written request for a hearing on the application on or before May 31, 2022.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on February 18, 2022, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchester, New Hampshire 03103, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance Drug code Schedule Cathinone 1235 I Methcathinone 1237 I Naphyrone 1258 I N-Ethylamphetamine 1475 I JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) 6250 I SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) 7008 I APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide 7048 I JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) 7081 I SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole 7104 I JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) 7118 I JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) 7122 I UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone 7144 I JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) 7203 I Ibogaine 7260 I Start Printed Page 25302 Lysergic acid diethylamide 7315 I Marihuana Extract 7350 I Marihuana 7360 I Tetrahydrocannabinols 7370 I Mescaline 7381 I JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) 7398 I 3,4-Methylenedioxymethamphetamine 7405 I 5-Methoxy-N-N-dimethyltryptamine 7431 I Psilocyn 7438 I 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) 7498 I MDPV (3,4-Methylenedioxypyrovalerone) 7535 I Methylone (3,4-Methylenedioxy-N-methylcathinone) 7540 I Butylone 7541 I Pentylone 7542 I Codeine-N-oxide 9053 I Desomorphine 9055 I Dihydromorphine 9145 I Heroin 9200 I Morphine-N-oxide 9307 I Normorphine 9313 I Tilidine 9750 I Alpha-methylfentanyl 9814 I Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) 9821 I Fentanyl-related substance 9850 I Methamphetamine 1105 II Phenmetrazine 1631 II Methylphenidate 1724 II Amobarbital 2125 II Pentobarbital 2270 II Secobarbital 2315 II Glutethimide 2550 II Phencyclidine 7471 II 4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II Norfentanyl 8366 II Phenylacetone 8501 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Diphenoxylate 9170 II Ecgonine 9180 II Ethylmorphine 9190 II Hydrocodone 9193 II Levorphanol 9220 II Meperidine 9230 II Meperidine intermediate-A 9232 II Meperidine intermediate-B 9233 II Meperidine intermediate-C 9234 II Methadone intermediate 9254 II Dextropropoxyphene, bulk (non-dosage forms) 9273 II Morphine 9300 II Thebaine 9333 II 14-Hydroxmorphone 9665 II Noroxymorphone 9668 II Sufentanil 9740 II Fentanyl 9801 II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Start SignatureMatthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-09057 Filed 4-27-22; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 04/28/2022
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2022-09057
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 31, 2022. Such persons may also file a written request for a hearing on the application on or before May 31, 2022.
- Pages:
- 25301-25302 (2 pages)
- Docket Numbers:
- Docket No. DEA-996
- PDF File:
- 2022-09057.pdf
- Supporting Documents:
- » Importer Application - VHG Labs DBA LGC Standard (2022-09057) - DEA996